Anebulo regains Nasdaq compliance on private placement share restrictions

Anebulo Pharmaceuticals, Inc.

Nasdaq confirmed compliance with Listing Rule 5635(b) on April 11, 2025.
Removal of voting and transfer restrictions on shares issued in December 2024 private placement was approved by stockholders.
Matter is now closed; no further delisting risk from this issue.
Company disclosed the resolution in an 8-K filed April 15, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.